• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤的 DNA 甲基化图谱显示出广泛的患者内和患者间异质性,从而推动了转录组的变异性。

The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variability.

机构信息

Université de Nantes, CNRS, INSERM, CRCINA, Nantes, F-44000, France.

Institut de Cancérologie de l'Ouest, Nantes-Saint Herblain, France.

出版信息

Genome Med. 2021 Aug 9;13(1):127. doi: 10.1186/s13073-021-00938-3.

DOI:10.1186/s13073-021-00938-3
PMID:34372935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8351364/
Abstract

BACKGROUND

Cancer evolution depends on epigenetic and genetic diversity. Historically, in multiple myeloma (MM), subclonal diversity and tumor evolution have been investigated mostly from a genetic perspective.

METHODS

Here, we performed an analysis of 42 MM samples from 21 patients by using enhanced reduced representation bisulfite sequencing (eRRBS). We combined several metrics of epigenetic heterogeneity to analyze DNA methylation heterogeneity in MM patients.

RESULTS

We show that MM is characterized by the continuous accumulation of stochastic methylation at the promoters of development-related genes. High combinatorial entropy change is associated with poor outcomes in our pilot study and depends predominantly on partially methylated domains (PMDs). These PMDs, which represent the major source of inter- and intrapatient DNA methylation heterogeneity in MM, are linked to other key epigenetic aberrations, such as CpG island (CGI)/transcription start site (TSS) hypermethylation and H3K27me3 redistribution as well as 3D organization alterations. In addition, transcriptome analysis revealed that intratumor methylation heterogeneity was associated with low-level expression and high variability.

CONCLUSIONS

We propose that disrupted DNA methylation in MM is responsible for high epigenetic and transcriptomic instability allowing tumor cells to adapt to environmental changes by tapping into a pool of evolutionary trajectories.

摘要

背景

癌症的进化取决于表观遗传和遗传多样性。在多发性骨髓瘤(MM)中,从历史上看,亚克隆多样性和肿瘤进化主要从遗传角度进行了研究。

方法

在这里,我们通过增强的简化重亚硫酸盐测序(eRRBS)对 21 名患者的 42 个 MM 样本进行了分析。我们结合了几种表观遗传异质性度量标准来分析 MM 患者的 DNA 甲基化异质性。

结果

我们表明,MM 的特征是与发育相关基因启动子处随机甲基化的不断积累。在我们的初步研究中,高组合熵变化与不良预后相关,并且主要取决于部分甲基化域(PMD)。这些 PMD 代表 MM 中患者间和患者内 DNA 甲基化异质性的主要来源,与其他关键的表观遗传异常(如 CpG 岛(CGI)/转录起始位点(TSS)过度甲基化和 H3K27me3 重新分布以及 3D 组织改变)相关。此外,转录组分析表明,肿瘤内甲基化异质性与低水平表达和高变异性相关。

结论

我们提出,MM 中破坏的 DNA 甲基化导致高表观遗传和转录组不稳定性,使肿瘤细胞能够通过利用一系列进化轨迹来适应环境变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b560/8351364/16bce3d776c7/13073_2021_938_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b560/8351364/7a22c40adca7/13073_2021_938_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b560/8351364/831c08a238e4/13073_2021_938_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b560/8351364/37dcc90e30e9/13073_2021_938_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b560/8351364/c63c748a61f4/13073_2021_938_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b560/8351364/3b2a974000bf/13073_2021_938_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b560/8351364/b95067b9ce96/13073_2021_938_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b560/8351364/16bce3d776c7/13073_2021_938_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b560/8351364/7a22c40adca7/13073_2021_938_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b560/8351364/831c08a238e4/13073_2021_938_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b560/8351364/37dcc90e30e9/13073_2021_938_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b560/8351364/c63c748a61f4/13073_2021_938_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b560/8351364/3b2a974000bf/13073_2021_938_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b560/8351364/b95067b9ce96/13073_2021_938_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b560/8351364/16bce3d776c7/13073_2021_938_Fig7_HTML.jpg

相似文献

1
The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variability.多发性骨髓瘤的 DNA 甲基化图谱显示出广泛的患者内和患者间异质性,从而推动了转录组的变异性。
Genome Med. 2021 Aug 9;13(1):127. doi: 10.1186/s13073-021-00938-3.
2
Genome-wide DNA methylome variation in two genetically distinct chicken lines using MethylC-seq.利用甲基化C测序技术研究两个遗传背景不同的鸡品系的全基因组DNA甲基化组变异
BMC Genomics. 2015 Oct 23;16:851. doi: 10.1186/s12864-015-2098-8.
3
An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.肺癌的综合表观基因组-转录组图谱揭示了具有诊断和治疗意义的新型甲基化驱动基因。
Theranostics. 2021 Mar 11;11(11):5346-5364. doi: 10.7150/thno.58385. eCollection 2021.
4
The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma.新诊断多发性骨髓瘤分子亚群中异常基因表达的功能表观遗传景观。
J Hematol Oncol. 2020 Aug 6;13(1):108. doi: 10.1186/s13045-020-00933-y.
5
Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma.实体瘤中的比较甲基化组分析揭示了鼻咽癌6号染色体短臂上的异常甲基化。
Cancer Med. 2015 Jul;4(7):1079-90. doi: 10.1002/cam4.451. Epub 2015 Apr 29.
6
Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma.多发性骨髓瘤中microRNA-155表达的表观遗传调控研究进展
Biochim Biophys Acta. 2015 Mar;1849(3):353-66. doi: 10.1016/j.bbagrm.2014.12.002. Epub 2014 Dec 11.
7
Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.探索启动子、基因内和基因间区域的DNA甲基化变化,作为乳腺癌形成过程中的早期和晚期事件。
BMC Cancer. 2015 Oct 29;15:816. doi: 10.1186/s12885-015-1777-9.
8
Integrative single-cell omics analyses reveal epigenetic heterogeneity in mouse embryonic stem cells.整合单细胞组学分析揭示了小鼠胚胎干细胞中的表观遗传异质性。
PLoS Comput Biol. 2018 Mar 21;14(3):e1006034. doi: 10.1371/journal.pcbi.1006034. eCollection 2018 Mar.
9
Epigenetic silencing of LPP/miR-28 in multiple myeloma.多发性骨髓瘤中 LPP/miR-28 的表观遗传沉默。
J Clin Pathol. 2018 Mar;71(3):253-258. doi: 10.1136/jclinpath-2017-204501. Epub 2017 Aug 3.
10
Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.5-氮杂-2'-脱氧胞苷在结直肠癌细胞中的去甲基化作用靶向基因组 DNA,而启动子 CpG 岛的甲基化持续存在。
BMC Cancer. 2010 Jul 12;10:366. doi: 10.1186/1471-2407-10-366.

引用本文的文献

1
Super enhancer acquisition drives expression of oncogenic PPP1R15B that regulates protein homeostasis in multiple myeloma.超级增强子的获得驱动致癌 PPP1R15B 的表达,该表达调控多发性骨髓瘤中的蛋白质稳态。
Nat Commun. 2024 Aug 9;15(1):6810. doi: 10.1038/s41467-024-50910-z.
2
Semimethylation is a feature of diffuse large B-cell lymphoma, and subgroups with poor prognosis are characterized by global hypomethylation and short telomere length.亚甲基化是弥漫性大 B 细胞淋巴瘤的一个特征,而预后不良的亚组则表现为整体低甲基化和端粒较短。
Clin Epigenetics. 2024 May 21;16(1):68. doi: 10.1186/s13148-024-01680-4.
3
Artificial Intelligence-Assisted Diagnostic Cytology and Genomic Testing for Hematologic Disorders.

本文引用的文献

1
Transition to naïve human pluripotency mirrors pan-cancer DNA hypermethylation.向原始人类多能性的转变反映了泛癌 DNA 高甲基化。
Nat Commun. 2020 Jul 22;11(1):3671. doi: 10.1038/s41467-020-17269-3.
2
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance.肿瘤内异质性:治疗抵抗的罗塞塔石碑。
Cancer Cell. 2020 Apr 13;37(4):471-484. doi: 10.1016/j.ccell.2020.03.007.
3
A Dysregulated DNA Methylation Landscape Linked to Gene Expression in MLL-Rearranged AML.与MLL重排急性髓系白血病基因表达相关的DNA甲基化景观失调
人工智能辅助诊断细胞学和血液病基因组检测。
Cells. 2023 Jun 30;12(13):1755. doi: 10.3390/cells12131755.
4
Study on the Effect of EZH2 Inhibitor Combined with TIGIT Monoclonal Antibody against Multiple Myeloma Cells.EZH2 抑制剂联合 TIGIT 单克隆抗体对多发性骨髓瘤细胞作用的研究。
Int J Mol Sci. 2023 May 11;24(10):8603. doi: 10.3390/ijms24108603.
5
Metheor: Ultrafast DNA methylation heterogeneity calculation from bisulfite read alignments.Metheor:从亚硫酸氢盐读取比对中计算超快 DNA 甲基化异质性。
PLoS Comput Biol. 2023 Mar 20;19(3):e1010946. doi: 10.1371/journal.pcbi.1010946. eCollection 2023 Mar.
6
Mechanistic Studies and a Retrospective Cohort Study: The Interaction between PPAR Agonists and Immunomodulatory Agents in Multiple Myeloma.机制研究与回顾性队列研究:过氧化物酶体增殖物激活受体激动剂与免疫调节剂在多发性骨髓瘤中的相互作用
Cancers (Basel). 2022 Oct 27;14(21):5272. doi: 10.3390/cancers14215272.
7
Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?多发性骨髓瘤中的异常DNA甲基化:主要障碍还是机遇?
Front Oncol. 2022 Aug 18;12:979569. doi: 10.3389/fonc.2022.979569. eCollection 2022.
8
Epialleles and epiallelic heterogeneity in hematological malignancies.血液系统恶性肿瘤中的表观等位基因和表观等位基因异质性。
Med Oncol. 2022 Jul 14;39(10):139. doi: 10.1007/s12032-022-01737-5.
9
MeConcord: a new metric to quantitatively characterize DNA methylation heterogeneity across reads and CpG sites.MeConcord:一种新的度量标准,用于定量描述跨读取和 CpG 位点的 DNA 甲基化异质性。
Bioinformatics. 2022 Jun 24;38(Suppl 1):i307-i315. doi: 10.1093/bioinformatics/btac248.
10
Multiple Myeloma: Challenges Encountered and Future Options for Better Treatment.多发性骨髓瘤:面临的挑战和更好治疗的未来选择。
Int J Mol Sci. 2022 Jan 31;23(3):1649. doi: 10.3390/ijms23031649.
Epigenetics. 2020 Aug;15(8):841-858. doi: 10.1080/15592294.2020.1734149. Epub 2020 Feb 29.
4
DNA Methylation Directs Polycomb-Dependent 3D Genome Re-organization in Naive Pluripotency.DNA 甲基化指导多梳依赖的 3D 基因组在原始多能性中的重新组织。
Cell Rep. 2019 Nov 12;29(7):1974-1985.e6. doi: 10.1016/j.celrep.2019.10.031.
5
Alterations in the Transcriptional Programs of Myeloma Cells and the Microenvironment during Extramedullary Progression Affect Proliferation and Immune Evasion.骨髓外进展过程中骨髓瘤细胞和微环境转录程序的改变影响增殖和免疫逃逸。
Clin Cancer Res. 2020 Feb 15;26(4):935-944. doi: 10.1158/1078-0432.CCR-19-0694. Epub 2019 Sep 26.
6
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load.DNA 甲基化缺失促进具有高突变和拷贝数负荷的肿瘤的免疫逃逸。
Nat Commun. 2019 Sep 19;10(1):4278. doi: 10.1038/s41467-019-12159-9.
7
Genomic landscape and chronological reconstruction of driver events in multiple myeloma.多发性骨髓瘤中驱动事件的基因组全景和时间重建。
Nat Commun. 2019 Aug 23;10(1):3835. doi: 10.1038/s41467-019-11680-1.
8
Role of network-mediated stochasticity in mammalian drug resistance.网络介导的随机性在哺乳动物药物抵抗中的作用。
Nat Commun. 2019 Jun 24;10(1):2766. doi: 10.1038/s41467-019-10330-w.
9
Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia.慢性淋巴细胞白血病的表观遗传进化和谱系历史。
Nature. 2019 May;569(7757):576-580. doi: 10.1038/s41586-019-1198-z. Epub 2019 May 15.
10
Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma.多发性骨髓瘤患者细胞遗传学预后指数的建立与验证:对生存的预测作用。
J Clin Oncol. 2019 Jul 1;37(19):1657-1665. doi: 10.1200/JCO.18.00776. Epub 2019 May 15.